Trials / Recruiting
RecruitingNCT06302270
CFTR Modulators in Pregnancy and Postpartum
Monitoring of Women and Children Exposed to the Combination of Elexacaftor-tezacaftor-ivacaftor During Bregnancy and Through Mother's Own Milk.
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 75 (estimated)
- Sponsor
- Region Stockholm · Other Government
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
Observational study on women with Cystic Fibrosis treated with CFTR modulators during pregnancy and postpartum and their children. Registration on maternal health parameters and effects of CFTR-modulators in the newborn infant as well as effects of exposure through mother's own milk.
Conditions
Timeline
- Start date
- 2024-03-15
- Primary completion
- 2034-01-31
- Completion
- 2039-01-31
- First posted
- 2024-03-08
- Last updated
- 2024-03-08
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT06302270. Inclusion in this directory is not an endorsement.